These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27286111)

  • 1. Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms.
    Maldonado-Avila M; Garduno-Arteaga L; Jungfermann-Guzman R; Manzanilla-Garcia HA; Rosas-Nava E; Procuna-Hernandez N; Vela-Mollinedo A; Almazan-Trevino L; Guzman-Esquivel J
    Int Braz J Urol; 2016; 42(3):487-93. PubMed ID: 27286111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.
    Sivalingam S; Streeper NM; Sehgal PD; Sninsky BC; Best SL; Nakada SY
    J Urol; 2016 Feb; 195(2):385-90. PubMed ID: 26393904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does tamsulosin or mirabegron improve ureteral stent-related symptoms? A prospective placebo-controlled study.
    Yavuz A; Kilinc MF; Aydin M; Ofluoglu Y; Bayar G
    Low Urin Tract Symptoms; 2021 Jan; 13(1):17-21. PubMed ID: 32408390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tamsulosin hydrochloride in relieving "double-J ureteral stent-related morbidity": a randomized placebo controlled clinical study.
    Singh I; Tripathy S; Agrawal V
    Int Urol Nephrol; 2014 Dec; 46(12):2279-83. PubMed ID: 25201459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tamsulosin, oxybutynin or their combination in the treatment of ureteral stent-related symptoms].
    Maldonado-Alcaraz E; Moreno-Palacios J; López-Sámano VA; Landa-Salas JD; Torres-Mercado LO; García-Cruz C
    Rev Med Inst Mex Seguro Soc; 2017; 55(5):568-574. PubMed ID: 29193937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.
    Ragab M; Soliman MG; Tawfik A; Abdel Raheem A; El-Tatawy H; Abo Farha M; Magdy M; Elashry O
    Int Urol Nephrol; 2017 Jun; 49(6):961-966. PubMed ID: 28260223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
    Dellis AE; Papatsoris AG; Keeley FX; Bamias A; Deliveliotis C; Skolarikos AA
    J Endourol; 2017 Jan; 31(1):100-109. PubMed ID: 27809592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial.
    Park J; Yoo C; Han DH; Shin DW
    World J Urol; 2015 Nov; 33(11):1833-40. PubMed ID: 25809877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
    Wang J; Zhang X; Zhang T; Mu J; Bai B; Lei Y
    World J Urol; 2017 Nov; 35(11):1669-1680. PubMed ID: 28550362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study.
    Wang CJ; Huang SW; Chang CH
    Urol Res; 2009 Jun; 37(3):147-52. PubMed ID: 19277623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.
    Liu S; Yu Y; Gao Y; Yang X; Pang Z
    Urolithiasis; 2016 Apr; 44(2):185-90. PubMed ID: 26242466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
    El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
    World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
    Wang CJ; Huang SW; Chang CH
    Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: a randomized controlled study.
    Navanimitkul N; Lojanapiwat B
    J Int Med Res; 2010; 38(4):1436-41. PubMed ID: 20926016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
    Jian Z; Chen Y; Liu Q; Liao B; Yang T; Li H; Wang K
    World J Urol; 2019 Feb; 37(2):289-297. PubMed ID: 30030658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study.
    Damiano R; Autorino R; De Sio M; Giacobbe A; Palumbo IM; D'Armiento M
    J Endourol; 2008 Apr; 22(4):651-6. PubMed ID: 18338955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized 'suture stent'.
    Betschart P; Piller A; Zumstein V; Schmid HP; Engeler DS; Güsewell S; Pratsinis M; Abt D
    BJU Int; 2021 May; 127(5):596-605. PubMed ID: 33152169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
    Shin YS; Zhang LT; You JH; Choi IS; Zhao C; Park JK
    Clin Interv Aging; 2016; 11():1301-1307. PubMed ID: 27698559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin oral intake therapy to relieve stent - related urinary symptoms and pain: a prospective, randomized, controlled study.
    Zhang L; Li J; Pan M; Han W; Liu S; Xiao Y
    Int Braz J Urol; 2016; 42(4):727-33. PubMed ID: 27564283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy and tolerance of short-duration open-ended ureteral catheter drainage and tamsulosin administration to indwelling double J stents following ureteroscopic removal of stones.
    Chauhan VS; Bansal R; Ahuja M
    Hong Kong Med J; 2015 Apr; 21(2):124-30. PubMed ID: 25756274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.